dakshadmin

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and heart conditions, are reaching epidemic proportions across Rajasthan. With a population of over 74.79 million, the state presents a massive and growing demand for medicines, nutraceuticals, and healthcare products. According to the Ministry of Health and Family Welfare, the incidence rate of diabetes in Rajasthan stands at approximately 6.2%, with the state reporting over 4.6 million type 2 diabetics. A community-based health screening in a rural village of Rajasthan found that the prevalence of generalized obesity was 20% and abdominal obesity was 39% among the screened population. The prevalence of diabetes was significantly higher in obese individuals—15% in those with generalized obesity and 12% in those with abdominal obesity—compared to their non-obese counterparts. This indicates a strong link between obesity and diabetes in the state. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Rajasthan families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Rajasthan 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Rajasthan patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Rajasthan Daksh works with hospitals, clinics, and pharmacies across Rajasthan to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and expanding healthcare infrastructure, there is immense potential to build a meaningful healthcare business while serving your community. The pharmaceutical market in Rajasthan is growing at more than 12% every year due to rising healthcare awareness, increasing lifestyle diseases, and better healthcare services in both cities and rural areas. Popular Locations for PCD Pharma Franchise in Rajasthan PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Jaipur Cardiac diabetic PCD company in Jaipur PCD pharma franchise in Jodhpur Cardiac diabetic products in Jodhpur PCD pharma franchise in Udaipur Diabetic cardiac PCD franchise in Udaipur PCD pharma franchise in Kota Cardiac diabetic PCD company in Kota PCD pharma franchise in Ajmer Cardiac diabetic products in Ajmer PCD pharma franchise in Bikaner Diabetic cardiac PCD franchise in Bikaner PCD pharma franchise in Alwar Cardiac diabetic PCD company in Alwar PCD pharma franchise in Sikar Cardiac diabetic products in Sikar PCD pharma franchise in Bharatpur Diabetic cardiac PCD franchise in Bharatpur PCD pharma franchise in Pali Cardiac diabetic PCD company in Pali Conclusion The diabetes and heart disease epidemic in Rajasthan is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Odisha with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Odisha with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are rapidly emerging as major public health challenges in Odisha. According to the Indian Council of Medical Research, the state’s diabetes prevalence has reached 10.7%, with pre-diabetes affecting 9.7% of the adult population. The burden is significantly higher in urban areas, where 14.7% of the population is affected by diabetes, while rural areas show a prevalence of 9.5%. Hypertension rates are even more alarming, affecting 26.3% of Odisha’s population. The prevalence is notably higher in urban areas (30.2%) compared to rural (25.8%). A significant finding is that 22.3% of the population is in the pre-hypertension stage, indicating a massive at-risk group that could develop full-blown hypertension without intervention. The primary drivers include the traditional Odia diet rich in high glycemic index foods like rice, high saturated fat from cooking oils, and sugar-rich sweets combined with sedentary occupations, stressful urban living in cities like Bhubaneswar, Cuttack, and Rourkela, declining physical activity, and tobacco use, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. A community-based study found that physical inactivity, abdominal obesity, and family history of diabetes are the strongest risk factors for diabetes in the state, while high salt intake, tobacco use, and alcohol consumption are significantly associated with hypertension. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Odisha families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Odisha 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Odisha patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Odisha Daksh works with hospitals, clinics, and pharmacies across Odisha to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Odisha PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Bhubaneswar Cardiac diabetic PCD company in Bhubaneswar PCD pharma franchise in Cuttack Cardiac diabetic products in Cuttack PCD pharma franchise in Rourkela Diabetic cardiac PCD franchise in Rourkela PCD pharma franchise in Berhampur Cardiac diabetic PCD company in Berhampur PCD pharma franchise in Sambalpur Cardiac diabetic products in Sambalpur PCD pharma franchise in Puri Diabetic cardiac PCD franchise in Puri PCD pharma franchise in Balasore Cardiac diabetic PCD company in Balasore PCD pharma franchise in Bhadrak Cardiac diabetic products in Bhadrak PCD pharma franchise in Jharsuguda Diabetic cardiac PCD franchise in Jharsuguda PCD pharma franchise in Koraput Cardiac diabetic PCD company in Koraput Conclusion The diabetes and heart disease burden in Odisha is not just a statistic it is a reality affecting thousands of families. With a diabetes prevalence of 10.7%, hypertension affecting 26.3%, and 22.3% in pre-hypertension, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Odisha with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Nagaland with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Nagaland with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Nagaland. The Chakhesang Naga tribe, one of the prominent communities in the state, has a hypertension prevalence of 36% and a diabetes prevalence of 18%, rates significantly higher than broader regional and national averages. A separate study among adults aged 25-64 in Mokokchung district found a hypertension prevalence of 43.2%. Hypertension is a leading cause of morbidity in the state, with 12,244 recorded cases and an incidence of 4.55 per 1,000 population. The primary drivers include lifestyle factors such as smokeless tobacco use (58.9% males, 49.6% females), current smoking (38.1% males), inadequate fruit and vegetable intake (80.1% males, 93.6% females), and alcohol consumption . Among Ao Nagas, urban dwellers show significantly higher rates of low physical activity, overweight/obesity, and clustering of multiple risk factors compared to rural populations, while villagers are more likely to be hypertensive. The state’s unique dietary habits, including smoked meat and fermented products, further contribute to the disease burden. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Nagaland families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Nagaland 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Nagaland patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Nagaland Daksh works with hospitals, clinics, and pharmacies across Nagaland to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Nagaland PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Kohima Cardiac diabetic PCD company in Kohima PCD pharma franchise in Dimapur Cardiac diabetic products in Dimapur PCD pharma franchise in Mokokchung Diabetic cardiac PCD franchise in Mokokchung PCD pharma franchise in Tuensang Cardiac diabetic PCD company in Tuensang PCD pharma franchise in Wokha Cardiac diabetic products in Wokha PCD pharma franchise in Zunheboto Diabetic cardiac PCD franchise in Zunheboto PCD pharma franchise in Phek Cardiac diabetic PCD company in Phek PCD pharma franchise in Mon Cardiac diabetic products in Mon PCD pharma franchise in Longleng Diabetic cardiac PCD franchise in Longleng PCD pharma franchise in Kiphire Cardiac diabetic PCD company in Kiphire Conclusion The diabetes and heart disease burden in Nagaland is not just a statistic—it is a reality affecting thousands of families. With a hypertension prevalence of 36%–43% in tribal populations, a diabetes prevalence of 18% among the Chakhesang tribe, and high rates of tobacco use and poor dietary habits, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Nagaland with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Mizoram with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Mizoram with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Mizoram. The state has shown an increase in cases of type 2 diabetes mellitus over the last few decades. A study among young adults in Aizawl found that 35% had a slightly elevated risk for type 2 diabetes, with a further 5% at moderate risk. Raised blood glucose was reported in 5.4% of the adult population. The burden of hypertension is equally concerning. Among adults, 49% are prehypertensive and 14.4% have Stage 1 hypertension. A community-based study found that 11.97% of individuals were hypertensive. Additionally, nearly half of the population has a clustering of three or more cancer and NCD risk factors. The primary drivers include the unique Mizoram dietary and lifestyle habits. The study identified fermented pork fat (Sa-um) as a potential risk factor for type 2 diabetes with an odds ratio of 18.98, along with tuibur (tobacco-infused water). Other contributing factors include smoked meat, excess salt consumption, betel leaf with areca nut chewing, alcohol consumption, and physical inactivity. The state also has one of the highest rates of tobacco use (77.1%) and consumption of fermented products (80%). The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Mizoram families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Mizoram 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Mizoram patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Mizoram Daksh works with hospitals, clinics, and pharmacies across Mizoram to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing healthcare sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Mizoram PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Aizawl Cardiac diabetic PCD company in Aizawl PCD pharma franchise in Lunglei Cardiac diabetic products in Lunglei PCD pharma franchise in Champhai Diabetic cardiac PCD franchise in Champhai PCD pharma franchise in Serchhip Cardiac diabetic PCD company in Serchhip PCD pharma franchise in Kolasib Cardiac diabetic products in Kolasib PCD pharma franchise in Lawngtlai Diabetic cardiac PCD franchise in Lawngtlai PCD pharma franchise in Mamit Cardiac diabetic PCD company in Mamit PCD pharma franchise in Saiha Cardiac diabetic products in Saiha PCD pharma franchise in Hnahthial Diabetic cardiac PCD franchise in Hnahthial PCD pharma franchise in Saitual Cardiac diabetic PCD company in Saitual Conclusion The diabetes and heart disease burden in Mizoram is not just a statistic—it is a reality affecting thousands of families. With the state recording a hypertension prevalence of 11.97%, 49% prehypertensive, and 35% slightly elevated diabetes risk, and 77.1% tobacco use, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Mizoram with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Meghalaya. According to a systematic review, the prevalence of pre-diabetes in Meghalaya is among the lowest in India at 2.4%. However, diabetes awareness in the state is also the lowest in the country, with only 14.4% of people aware of their condition. This indicates a critical gap in screening and early detection that leaves many patients undiagnosed and untreated. The prevalence of hypertension is also notable. A 2025 study among young adults aged 18-25 years in urban Shillong found that 17.9% had elevated blood pressure. National data indicates that hypertension prevalence among youth in Meghalaya varies from 9.16% at the state level. The Lancet study found that 24.3% of people in Meghalaya suffer from hypertension. The primary drivers include the traditional Meghalaya diet rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets combined with sedentary occupations, stressful urban living in cities like Shillong, declining physical activity, high tobacco consumption (52.5% currently), and alcohol use, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The state also has one of the highest cancer rates in India, with 176 cancer cases per one lakh population, further highlighting the burden of non-communicable diseases. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar  it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Meghalaya families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Meghalaya 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Meghalaya patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Meghalaya Daksh works with hospitals, clinics, and pharmacies across Meghalaya to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Meghalaya PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Shillong Cardiac diabetic PCD company in Shillong PCD pharma franchise in Tura Cardiac diabetic products in Tura PCD pharma franchise in Jowai Diabetic cardiac PCD franchise in Jowai PCD pharma franchise in Nongstoin Cardiac diabetic PCD company in Nongstoin PCD pharma franchise in Baghmara Cardiac diabetic products in Baghmara PCD pharma franchise in Williamnagar Diabetic cardiac PCD franchise in Williamnagar PCD pharma franchise in Resubelpara Cardiac diabetic PCD company in Resubelpara PCD pharma franchise in Amlarem Cardiac diabetic products in Amlarem PCD pharma franchise in Mawkyrwat Diabetic cardiac PCD franchise in Mawkyrwat PCD pharma franchise in Mairang Cardiac diabetic PCD company in Mairang Conclusion The diabetes and heart disease burden in Meghalaya is not just a statistic it is a reality affecting thousands of families. With the state recording the lowest diabetes awareness in India at 14.4%, a hypertension prevalence of 24.3%, and high tobacco consumption (52.5%), the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as a significant concern in Manipur. Hypertension is the third most important risk factor for non-communicable diseases in the region. A study on the prevalence and risk factors of hypertension among adults in rural areas of Manipur found that prevalence of hypertension among adults was 51.8%, with pre-hypertension prevalence of 30.7%. The study also revealed that 33.5% of the population had never measured their blood pressure, indicating a major gap in awareness and screening that leads to delayed diagnosis. The prevalence of hypertension was higher among females than males across all age groups. The primary drivers include the traditional Manipur diet rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets combined with sedentary occupations, stressful urban living, declining physical activity, tobacco use, and alcohol consumption, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The prevalence of generalized obesity and central obesity is also high, which are critical risk factors for the development of diabetes and hypertension. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Manipur families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Manipur 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Manipur patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Manipur Daksh works with hospitals, clinics, and pharmacies across Manipur to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Manipur PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Imphal Cardiac diabetic PCD company in Imphal PCD pharma franchise in Thoubal Cardiac diabetic products in Thoubal PCD pharma franchise in Bishnupur Diabetic cardiac PCD franchise in Bishnupur PCD pharma franchise in Churachandpur Cardiac diabetic PCD company in Churachandpur PCD pharma franchise in Ukhrul Cardiac diabetic products in Ukhrul PCD pharma franchise in Senapati Diabetic cardiac PCD franchise in Senapati PCD pharma franchise in Tamenglong Cardiac diabetic PCD company in Tamenglong PCD pharma franchise in Chandel Cardiac diabetic products in Chandel PCD pharma franchise in Jiribam Diabetic cardiac PCD franchise in Jiribam PCD pharma franchise in Kakching Cardiac diabetic PCD company in Kakching Conclusion The diabetes and heart disease burden in Manipur is not just a statistic it is a reality affecting thousands of families. With a hypertension prevalence of 51.8%, 30.7% in pre-hypertension, and 33.5% never having measured their blood pressure, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) 2023-24 reveals that lifestyle diseases, particularly diabetes and hypertension, are escalating rapidly across Maharashtra, with urban centers bearing the brunt of this crisis. The survey shows that 17.7% of men and 16% of women now have high blood sugar levels or are on diabetes medication—a significant jump from 13.6% and 12.4% respectively in NFHS-5 . In urban areas, the prevalence is even higher, with 20.4% of men and 19.3% of women affected, meaning nearly one in five urban adults is living with diabetes. The burden of hypertension is equally alarming. Overall, 27.7% of men and 24.9% of women have elevated blood pressure or are on medication. Among urban men, the figure touches 30% —nearly one in three men in Maharashtra’s cities is living with hypertension, while urban women record a prevalence of 26%. The NFHS-5 survey had already established Maharashtra’s diabetes prevalence at 13%, with urban areas showing 15% prevalence. District-level analysis from NFHS-5 revealed that Sindhudurg had the highest prevalence at 23.4% among men and 20.6% among women, followed by Mumbai Suburban (21% men, 19.7% women). The state also has a concerning prevalence of abdominal obesity—51.5% of urban women and 43.2% of urban men have increased waist-hip ratio, a key risk factor for diabetes and heart disease . The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Maharashtra families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Maharashtra 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Maharashtra patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Maharashtra Daksh works with hospitals, clinics, and pharmacies across Maharashtra to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The PCD pharma market in Maharashtra offers low investment (starting at approximately ₹25,000) with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Maharashtra PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Mumbai Cardiac diabetic PCD company in Mumbai PCD pharma franchise in Pune Cardiac diabetic products in Pune PCD pharma franchise in Nagpur Diabetic cardiac PCD franchise in Nagpur PCD pharma franchise in Nashik Cardiac diabetic PCD company in Nashik PCD pharma franchise in Aurangabad Cardiac diabetic products in Aurangabad PCD pharma franchise in Thane Diabetic cardiac PCD franchise in Thane PCD pharma franchise in Kolhapur Cardiac diabetic PCD company in Kolhapur PCD pharma franchise in Solapur Cardiac diabetic products in Solapur PCD pharma franchise in Dhule Diabetic cardiac PCD franchise in Dhule PCD pharma franchise in Jalgaon Cardiac diabetic PCD company in Jalgaon Conclusion The diabetes and heart disease epidemic in Maharashtra is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 17.7% among men and 16% among women, hypertension affecting 30% of urban men, and the highest number of US FDA-approved pharma plants in India, the burden and the opportunity are both immense. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Madhya Pradesh, affecting both urban and rural populations. The National Family Health Survey (NFHS-5) found that the prevalence of diabetes in Madhya Pradesh is 7.3%. A 2025 study in rural Madhya Pradesh found 5.1% of participants with diabetes, while a study among urban slum dwellers in Bhopal found a high burden of non-communicable diseases with significant gender disparities. The burden of hypertension is even more alarming. NFHS-5 data shows 11.4% of women and 14.9% of men aged 15 and above have hypertension. A 2026 study in rural MP found a hypertension prevalence of 27.6%. The 2023-24 National Non-Communicable Disease Monitoring Survey found that Madhya Pradesh had the highest prevalence of hypertension among the states surveyed, with rates as high as 36.3% in some districts . The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Madhya Pradesh families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Madhya Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Madhya Pradesh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Madhya Pradesh Daksh works with hospitals, clinics, and pharmacies across Madhya Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Madhya Pradesh PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Bhopal Cardiac diabetic PCD company in Bhopal PCD pharma franchise in Indore Cardiac diabetic products in Indore PCD pharma franchise in Jabalpur Diabetic cardiac PCD franchise in Jabalpur PCD pharma franchise in Gwalior Cardiac diabetic PCD company in Gwalior PCD pharma franchise in Ujjain Cardiac diabetic products in Ujjain PCD pharma franchise in Sagar Diabetic cardiac PCD franchise in Sagar PCD pharma franchise in Dewas Cardiac diabetic PCD company in Dewas PCD pharma franchise in Satna Cardiac diabetic products in Satna PCD pharma franchise in Ratlam Diabetic cardiac PCD franchise in Ratlam PCD pharma franchise in Rewa Cardiac diabetic PCD company in Rewa Conclusion The diabetes and heart disease epidemic in Madhya Pradesh is not just a statistic it is a reality affecting thousands of families. With a diabetes prevalence of 7.3%, hypertension affecting up to 36.3% in some districts, and significant undiagnosed cases, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care

Uncategorized /

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care Recent data reveals that Kerala has become India’s diabetes capital, with prevalence more than double the national average. According to the National Family Health Survey (NFHS-6) 2023-24, 31.9% of men and 28.9% of women in Kerala have high blood sugar levels or are on diabetes medication. This marks a sharp rise from 27.0% and 24.8% respectively in NFHS-5. The state leads the country in diabetes prevalence, with nearly one in three adult men now affected. The burden of hypertension is equally concerning. NFHS-6 data shows 31.9% of women and 36.6% of men have elevated blood pressure or are on medication. A spatial analysis of South India found Kerala exhibiting the highest hypertension prevalence, with significant clustering of cases across districts. A community-based study in Northern Kerala found a diabetes prevalence of 30% and an impaired glucose tolerance prevalence of 47.4%, indicating that nearly half the population is at high risk of developing diabetes. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Kerala families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Kerala 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Kerala patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Goa Daksh works with hospitals, clinics, and pharmacies across Kerala to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Goa PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Thiruvananthapuram Cardiac diabetic PCD company in Thiruvananthapuram PCD pharma franchise in Kochi Cardiac diabetic products in Kochi PCD pharma franchise in Kozhikode Diabetic cardiac PCD franchise in Kozhikode PCD pharma franchise in Thrissur Cardiac diabetic PCD company in Thrissur PCD pharma franchise in Kollam Cardiac diabetic products in Kollam PCD pharma franchise in Kannur Diabetic cardiac PCD franchise in Kannur PCD pharma franchise in Alappuzha Cardiac diabetic PCD company in Alappuzha PCD pharma franchise in Palakkad Cardiac diabetic products in Palakkad PCD pharma franchise in Malappuram Diabetic cardiac PCD franchise in Malappuram PCD pharma franchise in Kasaragod Cardiac diabetic PCD company in Kasaragod Conclusion The diabetes and heart disease epidemic in Kerala is not just a statistic—it is a reality affecting millions of families. With the state recording the highest diabetes prevalence in India at 31.9% among men and 28.9% among women, and hypertension affecting over 36% of men, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care Recent health data paints a concerning picture of Karnataka’s escalating diabetes and hypertension crisis. According to the National Family Health Survey (NFHS-5), the prevalence of diabetes in Karnataka is 8.4%, higher than the national average of 7.3%. However, more localized studies reveal even more alarming figures—a community-based study in rural Dakshina Kannada found a diabetes prevalence of 31.4%, with 63.5% unaware of their condition and only 52.1% of those treated achieving adequate blood sugar control. The state’s hypertension burden is equally severe, with 25% of women and 26.9% of men aged 15 and above having hypertension, exceeding the national averages of 21.3% and 24% respectively. A rural Bengaluru study found a diabetes prevalence of 10.9%, a prediabetes prevalence of 6.3%, and hypertension prevalence of 24.3%, with more than one-third of diabetics and three-fourths of hypertensives being newly diagnosed during screening. Karnataka has emerged as a focal point for non-communicable diseases, with 10.6% of the population now living with diabetes and a further 13.7% in the pre-diabetic stage, along with 31.5% affected by high blood pressure. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Karnataka families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Karnataka 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Karnataka patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Karnataka Daksh works with hospitals, clinics, and pharmacies across Karnataka to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Karnataka PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Bengaluru Cardiac diabetic PCD company in Bengaluru PCD pharma franchise in Mysuru Cardiac diabetic products in Mysuru PCD pharma franchise in Hubballi Diabetic cardiac PCD franchise in Hubballi PCD pharma franchise in Mangaluru Cardiac diabetic PCD company in Mangaluru PCD pharma franchise in Belagavi Cardiac diabetic products in Belagavi PCD pharma franchise in Kalaburagi Diabetic cardiac PCD franchise in Kalaburagi PCD pharma franchise in Davanagere Cardiac diabetic PCD company in Davanagere PCD pharma franchise in Ballari Cardiac diabetic products in Ballari PCD pharma franchise in Tumakuru Diabetic cardiac PCD franchise in Tumakuru PCD pharma franchise in Shivamogga Cardiac diabetic PCD company in Shivamogga Conclusion The diabetes and heart disease epidemic in Karnataka is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 8.4%, rural rates as high as 31.4%, and hypertension affecting 31.5%, the burden is already immense and growing. The high rates of undiagnosed disease and inadequate control create a pressing need for quality, accessible medications. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care Read More »